HighTower Advisors
ATOS icon

HighTower Advisors’s Atossa Therapeutics ATOS Stock Holding History

HighTower Advisors’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,340
Closed -$15K – 3643
2023
Q3 		$15K Hold
1,340
– – ﹤0.01% 3351
2023
Q2 		$25K Hold
1,340
– – ﹤0.01% 3234
2023
Q1 		$15K Hold
1,340
– – ﹤0.01% 3169
2022
Q4 		$10K Hold
1,340
– – ﹤0.01% 3173
2022
Q3 		$15K Hold
1,340
– – ﹤0.01% 2990
2022
Q2 		$20K Hold
1,340
– – ﹤0.01% 2994
2022
Q1 		$25K Hold
1,340
– – ﹤0.01% 3143
2021
Q4 		$30K Hold
1,340
– – ﹤0.01% 3071
2021
Q3 		$65K Buy
+1,340
New +$78K ﹤0.01% 2911

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $245B AUM 31.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return